Related Experiment Video
Updated: Feb 12, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells
1Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe Dong Road, Zhengzhou, Henan 450052, China.
Insights
Progranulin (PGRN) levels increase during Coxsackievirus B3 (CVB3) infection, reducing viral myocarditis severity. PGRN deficiency worsens disease, while PGRN treatment offers therapeutic potential for this cardiac condition.
Area of Science:
- Cardiology
- Immunology
- Virology
Background:
- Viral myocarditis, often caused by Coxsackievirus B3 (CVB3), is a significant cause of sudden cardiac death in young adults.
- Progranulin (PGRN), a growth factor with known anti-inflammatory properties, has an uncharacterized role in viral myocarditis pathogenesis.
Purpose of the Study:
- To investigate the expression and function of Progranulin (PGRN) in the context of Coxsackievirus B3 (CVB3)-induced viral myocarditis.
Main Methods:
- Assessed PGRN levels in plasma and cardiac tissues of infected mice.
- Utilized PGRN-deficient mice and recombinant PGRN treatment to evaluate its effects on CVB3-induced myocarditis.
- Analyzed immune cell responses (Th1, Th17, Treg) and cytokine production in vitro and in vivo.
- Investigated the role of the JAK/STAT pathway in PGRN-mediated immune regulation.
Main Results:
- PGRN levels were significantly upregulated post-CVB3 infection and negatively correlated with disease severity.
- PGRN deficiency exacerbated viral myocarditis, while PGRN treatment attenuated the condition in mice.
- PGRN suppressed Th1 and Th17 cell responses and cytokine production, independent of Treg cells.
- PGRN regulated Th1 and Th17 cell differentiation by inhibiting the JAK/STAT pathway.
Conclusions:
- Progranulin (PGRN) plays a critical protective role in mitigating Coxsackievirus B3 (CVB3)-induced viral myocarditis.
- PGRN demonstrates potential as a novel therapeutic target for treating viral myocarditis.
Abstract:
Viral myocarditis, which is caused by Coxsackievirus B3 (CVB3) infection, is a leading reason of sudden cardiac death in young adults. Progranulin (PGRN), a pleiotropic growth factor, has been shown to exert anti-inflammatory function in a variety of inflammatory diseases. However, the expression and function of PGRN in the pathogenesis of viral myocarditis remain largely unknown. In this study, we found that PGRN levels in plasma and cardiac tissues were significantly upregulated post CVB3 infection, and negative correlated with disease severity. PGRN deficiency significantly exacerbated, whereas recombinant PGRN treatment attenuated CVB3-induced myocarditis in mice. PGRN downregulated Th1 and Th17 cell responses and cytokine production in vitro and in vivo, whereas its effect on viral myocarditis was Treg cell independent. Furthermore, PGRN regulated Th1 and Th17 cells differentiation through inhibition of the JAK/STAT pathway. Therefore, our findings reveal a critical role for PGRN in reducing CVB3-induced myocarditis and suggest that PGRN maybe a novel therapeutic treatment for viral myocarditis.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Myocarditis I: Introduction
Viral Recombination
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Myocarditis IV: Nursing Management

